Updated May 30, 2013, at 7:30 p.m. to correct that approval was granted for the Endurant II Aorto-Uni-Iliac stent graft system.
Medtronic (NYSE:MDT) said the FDA granted pre-market approval for its Endurant II Aorto-Uni-Iliac stent graft to treat abdominal aortic aneurysms and clearance for the Sentrant introducer sheath used with the AUI device.